Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patients

This publication has 26 references indexed in Scilit:

• Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
  New England Journal of Medicine, 1990
• Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
  New England Journal of Medicine, 1990
• Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients
  Calcified Tissue International, 1989
• Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study
  Bone and Mineral, 1989
• Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25-dihydroxyvitamin D
  Journal of Bone and Mineral Research, 1986
• Preliminary observations of a form of coherence therapy for osteoporosis
  Calcified Tissue International, 1984
• Effects of Two Treatment Regimes with Synthetic Human Parathyroid Hormone Fragment on Bone Formation and the Tissue Balance of Trabecular Bone in Greyhounds
  Endocrinology, 1983
• Parathyroid Hormone Stimulates the Bone Apposition Rate Independently of Its Resorptive Action: Differential Effects of Intermittent and Continuous Administration*
  Endocrinology, 1982
• Effect of combined therapy with phosphate and calcitonin on bone volume in osteoporosis
  Metabolic Bone Disease and Related Research, 1980
• ANABOLIC EFFECT OF LOW DOSES OF A FRAGMENT OF HUMAN PARATHYROID HORMONE ON THE SKELETON IN POSTMENOPAUSAL OSTEOPOROSIS
  The Lancet, 1976